Results 91 to 100 of about 138,725 (257)

Improving the Success of Melanocyte Keratinocyte Transplantation Surgery in Vitiligo; The Role of JAK Inhibitors, and Ablative Laser Resurfacing

, 2021
Maggi Ahmed Refat
openalex   +1 more source

Buying into JAK Inhibitors [PDF]

Cancer Discovery, 2013
Abstract Gilead Sciences of Foster City, CA, has offered $510 million for YM BioSciences of Mississauga, Ontario, Canada, whose primary product, CYT387, is an early-stage JAK1 and JAK 2 inhibitor.
openaire   +1 more source

Refractory granuloma faciale successfully treated with adjunct topical JAK inhibitor

JAAD Case Reports, 2023
Ailynna Chen, MPH, Christina L. Harview, MD, Sydney E. Rand, BSBA, Jessica L. Harms, MD   +3 more
doaj   +1 more source

Presenting JAK inhibitor safety information to dermatology patients

JEADV Clinical Practice
Janus Kinase (JAK) inhibitors are treatment options for dermatologic conditions such as atopic dermatitis, psoriasis, vitiligo, and alopecia areata. Guidance on how to counsel patients on these novel treatments is limited.
Anthony J. Teixeira, Jessica Q. Duong, Shirley P. Parraga, Steven R. Feldman   +3 more
doaj   +1 more source

Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis

RMD Open
Objectives This study aimed to evaluate the risk of tuberculosis associated with the use of Janus kinase (JAK) inhibitors or biological disease-modifying antirheumatic drugs (bDMARDs) in patients diagnosed with rheumatoid arthritis (RA) in South Korea ...
Jin-Won Kwon, Yun-Kyoung Song, Jaehee Lee, Junwoo Jo   +3 more
doaj   +1 more source

Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway [PDF]

, 2003
Objective. Erythropoietin (EPO) is a key regulator of erythropoiesis, playing a role in both the proliferation and differentiation of erythroid cells.
Bieber, Boer, Chung, Decker, Gabrilove, Gonzalez, Goodnough, Gotoh, Haq, Jain, Jain, Jonk, Kaptein, Kirito, Kirito, Kirito, Lim, Millot, Miyazaki, Mulcahy, Ng, Schuringa, Schuringa, Schuringa, Smithgall, Socolovsky, Teglund, Tilbrook, Turkson, Watowich, Wen, Wen, Woetmann, Yokogami, Youssoufian, Yu, Zhang   +36 more
core   +1 more source

Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series

, 2023
Qingqing Xu, Xiaochen Wang, Anbo Yang, Wei Guo   +3 more
openalex   +2 more sources

JAK inhibitors: special issue foreword [PDF]

Expert Review of Clinical Immunology, 2022
James Galloway, Fabiola Atzeni
openaire   +3 more sources

Supplementary Table 1 from JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells

, 2023
Paula Kroon, Paul A. Berry, Michael J. Stower, Greta Rodrigues, Vincent M. Mann, Matthew Simms, Deepak Bhasin, Somsundaram Chettiar, Chenglong Li, Pui‐Kai Li, Norman J. Maitland, Anne T. Collins   +11 more
openalex   +1 more source

JAK Inhibitor Clinical Response in Polyarthritis: Case Report

Acta Clinica Croatica, 2015
The heterogeneity of rheumatoid arthritis (RA) presentation and molecular signature of RA subclasses in patients with early changes of small peripheral joints still remains a challenging problem.
Asja Stipić-Marković, Iva Ferček, Marta Čubela, Marinko Artuković, Ksenija Maštrović Radončič, Liborija Lugović-Mihić   +5 more
doaj